Defining the Survival Benchmark for Breast Cancer Patients with Systemic Relapse | Zendy

Simon B. Zeichner | Zendy; Tadeu Ambros | Zendy; John Zaravinos | Zendy; Alberto J. Montero | Zendy; Reshma Mahtani | Zendy; Eugene Ahn | Zendy; Aruna Mani | Zendy; Nathan Markward | Zendy; Charles L. Vogel | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Defining the Survival Benchmark for Breast Cancer Patients with Systemic Relapse

Author(s) -

Simon B. Zeichner,

Tadeu Ambros,

John Zaravinos,

Alberto J. Montero,

Reshma Mahtani,

Eugene Ahn,

Aruna Mani,

Nathan Markward,

Charles L. Vogel

Publication year - 2015

Publication title -

breast cancer basic and clinical research

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.741

H-Index - 23

ISSN - 1178-2234

DOI - 10.4137/bcbcr.s23794

Subject(s) - medicine , breast cancer , systemic therapy , metastatic breast cancer , cancer , oncology , disease , population , retrospective cohort study , surgery , environmental health

Our original paper, published in 1992, reported a median overall survival after first relapse in breast cancer of 26 months. The current retrospective review concentrates more specifically on patients with first systemic relapse, recognizing that subsets of patients with local recurrence are potentially curable.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research